Both in Pharmaceuticals
ALX Oncology Holdings vs BridgeBio Oncology Therapeutics
Over the past year ALXO returned −6.8% and BBOT returned −81.0%; their daily moves had a correlation of 0.13.
ALXO −6.8% BBOT −81.0%Growth of $1, one year, split-adjusted
| Metric | ALXO | BBOT |
|---|---|---|
| Price | $1.36 | $2.30 |
| Market cap | $188.1M | $184.4M |
| Today | +5.43% | −0.86% |
| 1 month | +22.5% | −34.3% |
| 6 months | −34.9% | −72.4% |
| Year to date | +20.4% | −81.6% |
| 1 year | −13.4% | −81.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $128.5M | $225.7M |
| Dividend yield | — | — |
| Volatility (60d) | 93.1% | 87.9% |
| Short % of float | 6.5% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).